Stanford University

Redcoat AI Emerges from Stealth with $4.24M in Funding to Revolutionize Cybersecurity in the Generative AI Era

Retrieved on: 
Thursday, March 14, 2024
Technology, Mobile, Wireless, Security, Communications, Software, Internet, Social Media, Data Management, Artificial Intelligence, SMS, Stanford University, Pear, Organization, Computer science, Pear VC, WhatsApp, Medical device

Founded by a team of seasoned cybersecurity and AI experts, Redcoat AI uses the latest AI innovations to build defenses against sophisticated cybersecurity attacks, including AI-powered social engineering attacks that use contextual information, deep fakes, and human-like interactions.

Key Points: 
  • Founded by a team of seasoned cybersecurity and AI experts, Redcoat AI uses the latest AI innovations to build defenses against sophisticated cybersecurity attacks, including AI-powered social engineering attacks that use contextual information, deep fakes, and human-like interactions.
  • “We founded Redcoat AI at a pivotal moment for cybersecurity.
  • With generative AI, bad actors now have the ability to craft highly realistic and hyper-personalized attacks with unprecedented sophistication and scale.
  • With today's funding announcement, Redcoat AI is poised to redefine the cybersecurity landscape.

Pearl Bio Inks Collaboration with Merck to Discover Novel Engineered Biologics

Retrieved on: 
Tuesday, March 12, 2024
Biotechnology, FDA, Diabetes, Health, Legal, Pharmaceutical, Professional Services, Oncology, Other Science, Research, Infectious Diseases, General Health, Genetics, Science, MSD, Entrepreneurship, Yale University, Partnership, Synthetic biology, Epitope, Khosla Ventures, Pearl, Merck & Co., Merck, GRO, Cancer, Stanford University, Scottish Register of Tartans, Pharmaceutical industry

Pearl Bio (a synthetic biology company backed by Khosla Ventures) today announced that it has entered a license, collaboration and option agreement with Merck, known as MSD outside of the United States and Canada, to discover biologic therapies comprising non-standard amino acids.

Key Points: 
  • Pearl Bio (a synthetic biology company backed by Khosla Ventures) today announced that it has entered a license, collaboration and option agreement with Merck, known as MSD outside of the United States and Canada, to discover biologic therapies comprising non-standard amino acids.
  • "Merck is excited to collaborate with Pearl, a pioneer in developing recoded organisms, to produce novel biologics enabled by synthetic chemistries,” shared Juan Alvarez, Vice President of Discovery Biologics at Merck Research Laboratories.
  • Backed by Khosla Ventures, Pearl Bio was launched by Scientific Co-Founders Drs.
  • (Pearl Bio) bringing together an exclusive platform technology to advance multi-functionalized biologics and biomaterials by encoding synthetic chemistries.

GBK Collective Adds Brand Strategist and Marketing Luminary Professor Kevin Lane Keller to Its Advisory Board

Retrieved on: 
Tuesday, March 12, 2024
Data Analytics, Consulting, Marketing, Communications, Professional Services, Research, Marketing management, Microsoft, Philip Kotler, Intel, Consumer, L.L.Bean, Business, Nike, Duke University, Knowledge, Journal, Journal of Consumer Research, Tuck School of Business, Marketing science, Dartmouth College, Textbook, Science, University, Ford, Postgraduate education, Faculty, Journal of Marketing Research, Marketing research, MBA, GBK, Samsung, T-Mobile, Fortune 500, Accenture, Stanford University, Multimedia, Procter & Gamble, Management

GBK Collective , a leading marketing strategy, consumer behavior and analytics consultancy, today announced that Professor Kevin Lane Keller has joined its advisory board.

Key Points: 
  • GBK Collective , a leading marketing strategy, consumer behavior and analytics consultancy, today announced that Professor Kevin Lane Keller has joined its advisory board.
  • View the full release here: https://www.businesswire.com/news/home/20240312554244/en/
    GBK Collective, a leading marketing strategy, consumer behavior and analytics consultancy, today announced that Professor Kevin Lane Keller has joined its advisory board.
  • Dr. Keller is the E. B. Osborn Professor of Marketing at the Tuck School of Business at Dartmouth College and a renowned marketing strategist and best-selling author.
  • “With Kevin joining our advisory board, we’re bolstering our capabilities for strategic positioning, brand equity measurement, and next-generation brand tracking.

Biswas Family Foundation, Milken Institute Announce $15 Million in Funding for Research at the Intersection of AI and Health

Retrieved on: 
Tuesday, March 12, 2024
Technology, General Health, Infectious Diseases, Foundation, Philanthropy, Science, Biotechnology, Health, Health Technology, Other Philanthropy, Other Science, Research, Other Technology, Other Health, Pharmaceutical, Artificial Intelligence, Oncology, Gladstone Institutes, Diagnosis, Health informatics, Harvard Medical School, Computational biology, SPARC, Transformative use, Test management, Computer science, Data science, Disease, Assistant, Massachusetts Institute of Technology, Associate, Chatbot, Partnership, Genetics, Patient, Common, Artificial intelligence, AI, Doctor of Philosophy, Interpretation, Investment, Stanford University, Milken Institute, Genetic distance, Medical device

The Biswas Family Foundation , in partnership with the Milken Institute Science Philanthropy Accelerator for Research and Collaboration (SPARC) , is pleased to announce the inaugural recipients of the Transformative Computational Biology Grant Program .

Key Points: 
  • The Biswas Family Foundation , in partnership with the Milken Institute Science Philanthropy Accelerator for Research and Collaboration (SPARC) , is pleased to announce the inaugural recipients of the Transformative Computational Biology Grant Program .
  • Five multidisciplinary research teams will receive nearly $14 million total in grant funding for projects aiming to drive translational impact and the advancement of artificial intelligence (AI) models in clinical settings for diagnosis and treatment.
  • Additional support to enhance AI and computational biology research, inclusive of a gift to the Arc Institute , marks a total of $15 million in giving for the Biswas Family Foundation for this interdisciplinary field, and the beginning of more support.
  • To learn more about the Transformative Computational Biology Grant Program and to read the Giving Smarter Guide, visit: https://bit.ly/3Vae8Kq .

Spirair, Developer of the First and Only Minimally Invasive Therapy for Mechanical Correction of Nasal Septal Deviation, Announces Appointment of Benjamin Bishop as Chief Executive Officer

Retrieved on: 
Tuesday, March 12, 2024
Surgery, Medical Devices, Health, Health Technology, Medical Supplies, NSD, Clinical Otolaryngology, PMID, Patient, Acquisition, NSR, Stanford University, NAO, Otorhinolaryngology, ENT, Therapy, Septum, Marketing, IRB, Pharmaceutical industry

Spirair™, an early-stage company pioneering minimally invasive solutions that help ENTs advance care for their patients, today announced the appointment of Benjamin Bishop as its chief executive officer.

Key Points: 
  • Spirair™, an early-stage company pioneering minimally invasive solutions that help ENTs advance care for their patients, today announced the appointment of Benjamin Bishop as its chief executive officer.
  • The company is developing a novel therapy for symptomatic nasal septal deviation (NSD) that supports and straightens minor deviations in the septum with a bioabsorbable implant.
  • Treatment options for symptomatic NSD have been limited to either over-the-counter medications to alleviate symptoms or invasive surgical techniques to address the structural issues that cause these symptoms.
  • were co-fellows in the program and identified an opportunity in the ENT space when they discovered the unmet need for a minimally invasive nasal septal deviation correction therapy to help address nasal airway obstruction.

Lirvana Labs Raises $5.3M to Bolster its Flagship Yeti Confetti™ Kids App, An AI Learning Platform for Children

Retrieved on: 
Thursday, April 4, 2024
Software as a service, Sibling, Clement, Learning, Non-governmental organization, Partnership, COVID-19, Education, Harvard University, School, Research, United Nations, Google Play, Bloom, Child, Literacy, AI, Common Core, Student, LLM, App Store (iOS/iPadOS), The Walt Disney Company, P&G, Stanford University, Machine learning, Mitch Kapor, Parent, Engineering, Taxonomy, UN

MENLO PARK, Calif., April 4, 2024 /PRNewswire/ -- Lirvana Labs, creator of the Yeti Confetti Kids app which provides an AI-powered personalized learning companion for preschool to elementary grade children, today announced it has raised $5.3M in early-stage financing led by Kapor Capital III, Transcend Capital Partners II, and Chingona Ventures. Lirvana Labs will use this funding to expand its flagship product, Yeti Confetti Kids app, focusing on how large language models (LLMs) and generative AI capabilities can be harnessed to deliver personalized learning opportunities for globally diverse environments. Lirvana Labs will also use the funds to pursue efficacy studies with leading research institutions plus further its partnerships with pilot schools and non-governmental organizations (NGOs).

Key Points: 
  • Lirvana Labs will use this funding to expand its flagship product, Yeti Confetti Kids app, focusing on how large language models (LLMs) and generative AI capabilities can be harnessed to deliver personalized learning opportunities for globally diverse environments.
  • Since the COVID-19 pandemic, online learning has become integral to every child's education as schools and parents embrace technology's evolving role.
  • Lirvana Labs' Yeti Confetti Kids harnesses AI and cognitive research to act as a versatile educational companion, while also empowering parents and teachers with actionable insights into each child's cognitive, social and emotional development.
  • To learn more about Lirvana Labs and Yeti Confetti Kids, please visit yeticonfettikids.com .

Enable Biosciences Appoints Will Robberts as Chief Financial Officer and Secures Strategic Funding

Retrieved on: 
Thursday, April 4, 2024
KPMG, Thomson Reuters, Growth, Health, CFO, SAN, University, Software, Doctor of Philosophy, Stanford University, Financial management, Bachelor, Enabling, Economics, University of California, Berkeley, Carolyn Bertozzi, Management

"We are thrilled to welcome Will Robberts as our new CFO," said David Seftel, M,D.

Key Points: 
  • "We are thrilled to welcome Will Robberts as our new CFO," said David Seftel, M,D.
  • "His extensive experience and proven track record in finance and operations make him an invaluable addition to our leadership team.
  • He has already significantly impacted the business by securing pivotal funding for the company to support key strategic initiatives."
  • A graduate of the University of Johannesburg, Will holds Bachelor's, Honors, and Master's degrees in Accounting, Economics, and Financial Management.

FORE Enterprise Announces Breakthrough AI Solution to Control Costly Turnover for Businesses

Retrieved on: 
Wednesday, April 3, 2024
Faculty, SVKM's NMIMS, Assistant, Intelligence, McKinsey & Company, Advisory Council, Kellogg School, Risk, Coffee, Management science, Acquisition, AI, HAI, University, Northwestern University, Churn, Meditation, Workforce, LOS, Stanford University, School, Management

LOS ANGELES, April 3, 2024 /PRNewswire/ -- FORE Enterprise, an AI-driven data analytics company, today announced the launch of its enterprise data services that enable businesses and investors to model and mitigate workforce attrition with unprecedented precision, preserving resources and institutional knowledge.

Key Points: 
  • LOS ANGELES, April 3, 2024 /PRNewswire/ -- FORE Enterprise, an AI-driven data analytics company, today announced the launch of its enterprise data services that enable businesses and investors to model and mitigate workforce attrition with unprecedented precision, preserving resources and institutional knowledge.
  • Each year, workforce attrition costs median-sized S&P 500 companies as much as $355 million in lost productivity, according to McKinsey & Co.
  • Yet many companies fail to analyze and control their turnover trajectory or rely on costly consultancies.
  • Users of FORE's Operations Analytics platform have benefited from up to a 17% decrease in voluntary turnover six months after intervention.

Energia Power Systems Launches Crowdfunding Campaign to Advance Trailblazing Sodium and Lithium-Ion Battery Technology

Retrieved on: 
Tuesday, April 2, 2024
Stanford University, Wefunder, The Company, Research, Regulation CF, Electric battery

NEW YORK, April 2, 2024 /PRNewswire/ -- Energia Power Systems, Inc. (the "Company", "Energia"), an innovative power storage company developing rechargeable and longer lasting sodium-ion and lithium-ion batteries, today announced the launch of its crowdfunding campaign on Wefunder.

Key Points: 
  • NEW YORK, April 2, 2024 /PRNewswire/ -- Energia Power Systems, Inc. (the "Company", "Energia"), an innovative power storage company developing rechargeable and longer lasting sodium-ion and lithium-ion batteries, today announced the launch of its crowdfunding campaign on Wefunder.
  • Emerging from distinguished research labs of Stanford University, Energia is developing groundbreaking, rechargeable sodium-ion and lithium-ion batteries featuring a thionyl chloride-based electrolyte.
  • "The dream of a clean, but powerful, energy future shouldn't be reserved for the big players," said Joseph Hernandez, Chairman and Chief Executive Officer of Energia.
  • Energia welcomes everyone to be a part of the future of clean, rechargeable, and powerful energy storage solutions.

American Battery Technology Company Appoints Financial Industry Veteran, Susan Yun Lee, to Board of Directors

Retrieved on: 
Friday, March 29, 2024
Eli Broad, Culture, Master, American Battery Technology Company, The Walt Disney Company, Growth, Recycling, Partnership, Business administration, Harvard Business School, Phi Beta Kappa, Investment, ABTC, Stanford University, Economics, ABAT, Management

RENO, Nev., March 29, 2024 /PRNewswire/ -- American Battery Technology Company (ABTC) (NASDAQ: ABAT), an integrated critical battery materials company that is commercializing its technologies for both primary battery minerals manufacturing and secondary minerals lithium-ion battery recycling, today announced that financial industry veteran, Susan Yun Lee, will join the ABTC Board of Directors effective April 1, 2024.

Key Points: 
  • RENO, Nev., March 29, 2024 /PRNewswire/ -- American Battery Technology Company (ABTC) (NASDAQ: ABAT), an integrated critical battery materials company that is commercializing its technologies for both primary battery minerals manufacturing and secondary minerals lithium-ion battery recycling, today announced that financial industry veteran, Susan Yun Lee, will join the ABTC Board of Directors effective April 1, 2024.
  • "We are excited to welcome Susan to the ABTC Board," stated ABTC Chairman Rick Fezell.
  • "Her expertise in financial markets will be invaluable in reinforcing ABTC's strong culture of fiscal stewardship."
  • "I'm greatly looking forward to joining the ABTC team at such an exciting time in the rapidly growing domestic battery critical minerals industry," stated incoming board member Susan Yun Lee.